Education
About Us
Working with TipRanks
Follow Us
Neuland Laboratories Ltd. (IN:NEULANDLAB)
:NEULANDLAB
Total Valuation
Neuland Laboratories Ltd. has a market cap or net worth of ₹179.44B. The enterprise value is ₹196.20B.
Market Cap₹179.44B
Enterprise Value₹196.20B
Share Statistics
Neuland Laboratories Ltd. has 12,829,889 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,829,889
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neuland Laboratories Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 10.98%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)10.98%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee8.99M
Profits Per Employee2.11M
Employee Count1,643
Asset Turnover0.68
Inventory Turnover1.95
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio69.0
PS Ratio0.00
PB Ratio12.85
Price to Fair Value9.66
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-5.68
Income Statement
In the last 12 months, Neuland Laboratories Ltd. had revenue of 14.77B and earned 2.60B in profits. Earnings per share was 202.74.
Revenue14.77B
Gross Profit7.26B
Operating Income2.58B
Pretax Income3.46B
Net Income2.60B
EBITDA4.20B
Earnings Per Share (EPS)202.74
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Neuland Laboratories Ltd. pays an annual dividend of ₹12, resulting in a dividend yield of 0.09%
Dividend Per Share₹12
Dividend Yield0.09%
Payout Ratio7.62%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.57
52-Week Price Change67.22%
50-Day Moving Average12.34K
200-Day Moving Average13.13K
Relative Strength Index (RSI)57.01
Average Volume (3m)12.04K
Important Dates
Neuland Laboratories Ltd. upcoming earnings date is Jul 31, 2025, TBA (Confirmed).
Last Earnings DateMay 15, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend DateJul 18, 2025
Financial Position
Neuland Laboratories Ltd. as a current ratio of 2.45, with Debt / Equity ratio of 10.31%
Current Ratio2.45
Quick Ratio1.62
Debt to Market Cap<0.01
Net Debt to EBITDA0.06
Interest Coverage Ratio31.06
Taxes
In the past 12 months, Neuland Laboratories Ltd. has paid 862.21M in taxes.
Income Tax862.21M
Effective Tax Rate0.25
Enterprise Valuation
Neuland Laboratories Ltd. EV to EBITDA ratio is 35.13, with an EV/FCF ratio of 133.06.
EV to Sales9.99
EV to EBITDA35.13
EV to Free Cash Flow133.06
EV to Operating Cash Flow46.50
Balance Sheet
Neuland Laboratories Ltd. has ₹3.69B in cash and marketable securities with ₹1.57B in debt, giving a net cash position of -₹2.12B billion.
Cash & Marketable Securities₹3.69B
Total Debt₹1.57B
Net Cash-₹2.12B
Net Cash Per Share-₹164.91
Tangible Book Value Per Share₹966.87
Margins
Gross margin is 43.13%, with operating margin of 17.45%, and net profit margin of 17.61%.
Gross Margin43.13%
Operating Margin17.45%
Pretax Margin23.45%
Net Profit Margin17.61%
EBITDA Margin28.45%
EBIT Margin24.01%
Analyst Forecast
The average price target for Neuland Laboratories Ltd. is ₹15,750.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹15,750.00
Price Target Upside12.61% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-5.24%
EPS Growth Forecast-13.32%